Form 4 Tracker
HALOZYME THERAPEUTICS, INC.
HALO

25 insider filings · Latest: May 11, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Jan 5, 2026Jan 5 9:39 PMBERNADETTE CONNAUGHTON
Proposed Sale
2,000$70.31$140.6K

View →

Oct 1, 2025Oct 1 8:26 PMHelen Torley
Proposed Sale
136,569$73.34$10.0M

View →

Sep 10, 2025Sep 10 8:37 PMNICOLE LABROSSE
Proposed Sale
22,227$76.07$1.7M

View →

Sep 2, 2025Sep 2 8:38 PMBERNADETTE CONNAUGHTON
Proposed Sale
8,829$73.15$645.8K

View →

Jun 20, 2025Jun 20 8:25 PMHelen Torley
Proposed Sale
240,000$53.15$12.8M

View →

Feb 25, 2025Feb 25 9:32 PMMICHAEL LABARRE
Proposed Sale
21,697$58.50$1.3M

View →

Feb 3, 2025Feb 3 9:21 PMJEFFREY HENDERSON
Proposed Sale
15,000$56.64$849.6K

View →

Jan 6, 2025Jan 6 9:26 PMJEFFREY HENDERSON
Proposed Sale
10,000$47.74$477.4K

View →

Oct 16, 2024Oct 16 8:14 PMMICHAEL LABARRE
Proposed Sale
10,000$53.26$532.6K

View →

Oct 15, 2024Oct 15 8:34 PMMICHAEL LABARRE
Proposed Sale
10,000$53.75$537.5K

View →

Oct 9, 2024Oct 9 8:09 PMHELEN TORLEY
Proposed Sale
10,000$52.58$525.8K

View →

Oct 8, 2024Oct 8 8:08 PMHELEN TORLEY
Proposed Sale
10,000$54.00$540.0K

View →

Sep 26, 2024Sep 26 8:05 PMHELEN TORLEY
Proposed Sale
10,000$56.10$561.0K

View →

Sep 25, 2024Sep 25 8:00 PMHELEN TORLEY
Proposed Sale
10,000$56.34$563.4K

View →

Sep 24, 2024Sep 24 8:05 PMHELEN TORLEY
Proposed Sale
10,000$58.21$582.1K

View →

Sep 18, 2024Sep 18 8:01 PMMICHAEL LABARRE
Proposed Sale
10,000$62.03$620.3K

View →

Sep 17, 2024Sep 17 8:03 PMMICHAEL LABARRE
Proposed Sale
10,000$62.88$628.8K

View →

Sep 12, 2024Sep 12 8:12 PMHELEN TORLEY
Proposed Sale
10,000$59.20$592.0K

View →

Sep 11, 2024Sep 11 8:05 PMHELEN TORLEY
Proposed Sale
10,000$59.09$590.9K

View →

Sep 10, 2024Sep 10 8:16 PMHELEN TORLEY
Proposed Sale
10,000$59.09$590.9K

View →

← Previous

Page 2 of 2

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Feb 20, 2026Feb 24 11:16 PMMark Howard SnyderSVP, CHIEF LEGAL OFFICER
Option Exercise
5,332$0.0015,995(D)

View →

Feb 23, 2026Feb 24 11:14 PMNicole LabrosseSVP, CHIEF FINANCIAL OFFICER
Option Exercise
6,688$0.0036,357(D)

View →

Feb 20, 2026Feb 24 11:14 PMNicole LabrosseSVP, CHIEF FINANCIAL OFFICER
Option Exercise
5,332$0.0015,995(D)

View →

Feb 23, 2026Feb 24 11:12 PMHelen TorleyDirector, PRESIDENT AND CEO
Option Exercise
22,436$0.0044,872(D)

View →

Feb 20, 2026Feb 24 11:12 PMHelen TorleyDirector, PRESIDENT AND CEO
Option Exercise
16,757$0.0050,270(D)

View →

Feb 16, 2026Feb 17 11:53 PMMark Howard SnyderSVP, CHIEF LEGAL OFFICER
Option Exercise
16,812$0.000(D)

View →

Feb 16, 2026Feb 17 11:52 PMNicole LabrosseSVP, CHIEF FINANCIAL OFFICER
Option Exercise
23,773$0.000(D)

View →

Feb 16, 2026Feb 17 11:51 PMHelen TorleyDirector, PRESIDENT AND CEO
Option Exercise
89,055$0.000(D)

View →

Feb 9, 2026Feb 12 2:21 AMCortney CaudillSVP, CHIEF OPERATING OFFICER
Grant/Award
44,248$80.4814,751(D)

View →

Feb 9, 2026Feb 12 2:20 AMMark Howard SnyderSVP, CHIEF LEGAL OFFICER
Grant/Award
78,087$80.4829,502(D)

View →

Feb 9, 2026Feb 12 2:20 AMNicole LabrosseSVP, CHIEF FINANCIAL OFFICER
Grant/Award
42,117$0.0029,502(D)

View →

Feb 9, 2026Feb 12 1:56 AMHelen TorleyDirector, PRESIDENT AND CEO
Grant/Award
241,366$80.4892,714(D)

View →

Feb 5, 2026Feb 6 12:38 AMHelen TorleyDirector, PRESIDENT AND CEO
Option Exercise
10,000$12.07201,923(D)

View →

Feb 4, 2026Feb 6 12:38 AMHelen TorleyDirector, PRESIDENT AND CEO
Option Exercise
20,000$12.07211,923(D)

View →

Feb 3, 2026Feb 6 12:38 AMHelen TorleyDirector, PRESIDENT AND CEO
Option Exercise
20,000$12.07231,923(D)

View →

← Previous

Page 2 of 2